Post-surgery Option for Liver Cancer
New study finds drug combination after surgery helps prevent recurrence in liver cancer patients.
Progress Against Cancer
New study finds drug combination after surgery helps prevent recurrence in liver cancer patients.
The 2015 approval of an immune checkpoint inhibitor for renal cell carcinoma (RCC) provided a much-needed new treatment option...
Accumulating research shows lifelong stressors degrade health and increase cancer risk, but exercise might help counteract the impact of...
Study finds mRNA vaccine can help prevent cancer recurrence in advanced melanoma patients.
The plenary program of the AACR Annual Meeting 2023 kicked off Saturday, April 15, with a session titled “Beating...
Researchers are striving to understand why men are more likely than women to get and die from many types...
While colorectal cancer incidence has gone down among older people, incidence rates have steadily increased for people under age...
Immunotherapy combination treatments are the first choice for treating many advanced cancers, and more combinations are coming.
Outside the lab, Frank McCormick, PhD, FAACR, is a racecar driver, nurturing a passion he developed decades ago. (“We...
Protein signatures in the blood could help guide physicians in choosing among different immunotherapy drugs.